1.28% 0.0082

Femasys Inc (FEMY)

개요 뉴스 가격 이력 Financials FEMY 왜 하락? 토론 예측

Relative Volume:

Femasys Inc Stock (FEMY) Company Profile

Healthcare (1115)

770-500-3910

3950 JOHNS CREEK COURT, SUWANEE

최신 SEC 제출 서류

FEMY's Discussions on Twitter

FEMY을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
FEMY Femasys Inc	0.6505	38.22M	950.10K	-16.69M	-15.16M	-0.83
ISRG Intuitive Surgical Inc	535.00	191.90B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	207.11	59.36B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	79.00	39.13B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	257.58	38.05B	5.26B	1.44B	1.76B	9.7713
MDLN Medline Inc	44.12	33.62B	27.43B	1.27B	1.01B	1.5829

Femasys Inc Stock (FEMY) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-11-20	개시	Laidlaw	Buy

Femasys Inc 주식(FEMY)의 최신 뉴스

Femasys Inc (FEMY) 재무 분석

Femasys Inc (FEMY)

Femasys Inc Stock (FEMY) Company Profile

FEMY을(를) 다른 주식과 비교

Femasys Inc Stock (FEMY) Upgrades & Downgrades

Femasys Inc 주식(FEMY)의 최신 뉴스

Returns Recap: Does Ares Management Corporation meet Warren Buffetts criteria2025 Earnings Impact & Growth Oriented Trading Recommendations - baoquankhu1.vn

Femasys Receives Nasdaq Extension to Regain Listing Compliance - TipRanks

Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule - Investing.com

Femasys Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets

Stock Recap: Will FUFU benefit from geopolitical trendsCPI Data & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Sahm

Femasys receives 180-day Nasdaq extension to meet minimum bid price - Investing.com Nigeria

Femasys receives 180-day Nasdaq extension to meet minimum bid price By Investing.com - Investing.com South Africa

Femasys secures Nasdaq extension to regain bid price compliance - MSN

Nasdaq gives Femasys more time to fix sub-$1 share price by July 2026 - Stock Titan

Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment - Investing.com Nigeria

Dow Update: Why Femasys Inc stock attracts global investorsTrade Volume Summary & AI Forecast Swing Trade Picks - Bộ Nội Vụ

Femasys Inc. Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed®? in Community-Based Care - marketscreener.com

Femasys Inc. Partners with Refuah Health Center to Enhance Accessibility of FemaSeed for Infertility Treatment - Quiver Quantitative

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care - The Manila Times

Community clinic partnership brings first-line FemaSeed fertility care closer - Stock Titan

Will Femasys Inc. stock maintain growth storyGap Up & Reliable Breakout Stock Forecasts - Улправда

What valuation multiples suggest for Femasys Inc. stockJuly 2025 Update & Safe Capital Growth Stock Tips - Улправда

Published on: 2026-01-09 05:32:45 - Улправда

Can Femasys Inc. stock rebound after recent weaknessPortfolio Return Report & Expert Approved Trade Ideas - Улправда

How Femasys Inc. stock performs after earnings2025 Price Momentum & Weekly High Momentum Picks - Улправда

Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 By Investing.com - Investing.com Nigeria

How Femasys Inc. stock reacts to inflationary pressures2026 world cup usa national team group stage goalkeepers counter attacking expert forecast guide - ulpravda.ru

Earnings Beat: Will MARZ stock keep high P E multiples2025 Biggest Moves & Pattern Based Trade Signal System - moha.gov.vn

Femasys gains UK approval for women's health products - MSN

Market Leaders: How strong is Femasys Inc stock balance sheetQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - Bộ Nội Vụ

User | theeveningleader.comFemasys Inc.Common Stock (Nasdaq:FEMY) Stock Quote - FinancialContent

Femasys files for at-the-market offering of up to $9.8 million in common stock - Investing.com Australia

Femasys Launches At-the-Market Common Stock Offering - TipRanks

Femasys files for at-the-market offering of up to $9.8 million in common stock By Investing.com - Investing.com South Africa

Suwanee company Femasys Inc. gets FDA approval for diagnostic device - The Business Journals

Contemporary OB/GYN week in review: FemVue clearance, flibanserin approval, and more - Contemporary OB/GYN

Swing Trade: Why Femasys Inc. stock is a must watch in 20252025 Geopolitical Influence & Accurate Intraday Trading Signals - Улправда

What momentum indicators show for Femasys Inc. stockMarket Sentiment Review & Risk Managed Trade Strategies - Bölüm Sonu Canavarı

Why Femasys Inc. stock is rated strong buyJuly 2025 Momentum & Real-Time Volume Spike Alerts - Улправда

Femasys receives FDA clearance for FemVue Controlled diagnostic device By Investing.com - Investing.com Australia

How interest rate cuts could boost Femasys Inc. stockMarket Growth Review & Technical Entry and Exit Tips - Bölüm Sonu Canavarı

How strong is Femasys Inc. stock balance sheet2025 Trading Recap & Consistent Profit Focused Trading Strategies - DonanımHaber

Why Femasys Inc. stock is a must watch in 20252025 Market Sentiment & Growth Oriented Trade Recommendations - Улправда

What analyst consensus says on Femasys Inc. stockJuly 2025 Action & AI Powered Market Trend Analysis - DonanımHaber

Femasys Earnings Notes - Trefis

PharmaCyte Biotech (Nasdaq: PMCB) reports Q2 loss and details QCLS, Femasys deals - Stock Titan

Femasys Inc. Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device - marketscreener.com

FDA clears FemVue Controlled for in-office tubal assessment - Contemporary OB/GYN

Femasys secures U.S. FDA clearance for next-generation Femvue diagnostic device - marketscreener.com

Femasys Gains FDA Clearance for FemVue Diagnostic Device - TipRanks

Femasys gains FDA clearance for FemVue diagnostic device - MSN

Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device - The Manila Times

Femasys Inc Secures FDA Clearance for FemVue Diagnostic Device - TradingView — Track All Markets

Femasys (NASDAQ: FEMY) secures FDA clearance for next-generation FemVue diagnostic - Stock Titan

Femasys receives FDA clearance for FemVue Controlled diagnostic device - Investing.com

Femasys Inc (FEMY) 재무 분석

매출

순이익

현금흐름

주당 순 이익

FEMY과 유사한 종목